Harbour Investments »

Amylyx Pharmaceuticals shares owned by Harbour Investments

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Harbour Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2k 90 13.59
2025-06-30 $576 90 6.41
2025-03-31 $318 90 3.54
2024-12-31 $340 90 3.78

More positions owned by Harbour Investments

Vanguard Index Fds &p 500 Etf Shs (VOO)
Invesco Qqq Tr Nit Ser 1 (QQQ)
First Tr Exchange-traded Mid Risng Etf (SDVY)
First Tr Exchng Traded Fd Vi T Vest Laddered (BUFR)
Ishares Tr Ore S&p Mcp Etf (IJH)
First Tr Exchng Traded Fd Vi Mith Unconstrai (UCON)
Apple Om (AAPL)
Ishares Tr Ore S&p500 Etf (IVV)
First Tr Exchange-traded Ap Strength Etf (FTCS)
Schwab Strategic Tr S Lrg Cap Etf (SCHX)
Spdr S&p 500 Etf Tr R Unit (SPY)
Spdr Series Trust Ortfolio S&p500 (SPLG)
Schwab Strategic Tr S Dividend Eq (SCHD)
Nvidia Corporation Om (NVDA)
Capital Grp Fixed Incm Etf T Ore Plus Incm (CGCP)

View all positions for Harbour Investments

Top funds holding Amylyx Pharmaceuticals

FMR
Perceptive Advisors
BlackRock
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Saturn V Capital Management
Commodore Capital
First Light Asset Management
Point72 Asset Management
Henderson Group
Driehaus Capital Management
Almitas Capital
Goldman Sachs Group
Paradigm Biocapital Advisors

View all funds holding Amylyx Pharmaceuticals